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MicroRNAs have been implicated as regulators of embryonic stem (ES) cell self-renewal and 
pluripotency. In this issue, Xu et al. (2009) demonstrate that miR-145 facilitates ES cell differentia-
tion by repressing the core pluripotency factors OCT4, SOX2, and KLF4, thereby silencing the 
self-renewal program.Embryonic stem (ES) cells are charac-
terized by two distinguishing attributes: 
their ability to adopt any cell fate (pluri-
potency) and their unlimited capacity 
for self-renewal. These unique abilities 
are maintained by a core network of 
transcription factors, including OCT4, 
SOX2, NANOG, and KLF4, that coop-
erate in complex regulatory circuits to 
ensure appropriate ES cell behavior. 
The importance of posttranscriptional 
control in diverse biological processes 
suggests an additional level of regula-
tion of stem cell phenotypes. Indeed, 
numerous lines of evidence now impli-
cate the microRNA (miRNA) family of 
posttranscriptional regulators as central 
players in the maintenance of normal 
ES cell function. Now, Xu et al. (2009) 
report in this issue of Cell that miR-145, 
an miRNA induced during differentia-
tion, directly silences the stem cell self-
renewal and pluripotency program.606 Cell 137, May 15, 2009 ©2009 Elsevier IGenetic disruption of the essential 
miRNA biogenesis factors Dicer and 
Dgcr8 in the mouse results in numer-
ous defects in ES cell behavior, includ-
ing impaired self-renewal, diminished 
expression of pluripotency markers, and 
a failure to execute induced programs of 
differentiation (Kim, 2008). Recent stud-
ies have begun assigning the activity of 
specific miRNAs to these critical ES cell 
functions. For example, the miR-290 clus-
ter (expressed in the mouse), the miR-371 
cluster (expressed in humans), and the 
miR-302 cluster (expressed in both) are 
direct regulators of the cell cycle in ES 
cells (Figure 1). Interestingly, the promot-
ers of each of these miRNA clusters are 
bound by core ES cell transcription fac-
tors, and each cluster encodes miRNAs 
with a shared seed sequence that is very 
similar to that of the oncogenic miR-17 
family. Repression of the cyclin-depen-
dent kinase inhibitor Cdkn1a (p21), a nc.shared target of these miRNAs, promotes 
rapid transit through the cell cycle, a key 
aspect of stem cell self-renewal.
Beyond this established role for 
miRNAs in ES cell proliferation, it is 
less clear whether miRNAs contribute 
to the restricted expression of pluripo-
tency factors during stem cell differen-
tiation. Recent work in murine ES cells 
has uncovered evidence for the miRNA-
mediated regulation of pluripotency 
factors (Tay et al., 2008), but the extent 
and importance of endogenous miRNAs 
in the regulation of the human ES cell 
core transcriptional network remains 
unknown. In their new work, Xu et al. 
(2009) address this issue by demonstrat-
ing that miRNAs regulate the expression 
and function of the human ES cell pluri-
potency machinery.
After an initial profiling analysis of 
miRNA expression during the differentia-
tion of human ES cells into embryoid bod-
ies in vitro, the authors noted a dramatic 
upregulation in expression of miR-145, an 
miRNA predicted to target the pluripotency 
factors OCT4, SOX2, and KLF4. Reporter 
studies as well as miRNA gain- and loss-
of-function experiments demonstrated 
convincingly that the transcripts encoding 
these pluripotency factors represent bona 
fide targets of miR-145. Consistent with 
these findings, enforced expression of 
miR-145 in human ES cells blocked self-
renewal (manifested by reduced expres-
sion of the SSEA4 self-renewal marker 
and reduced numbers of cells in S phase) 
and induced expression of mesodermal 
and ectodermal differentiation markers. 
Inhibition of miR-145 with antisense oli-
gonucleotides increased the self-renewal 
of human ES cells. Finally, the authors 
noted the presence of a consensus OCT4 
binding motif ?1 kb upstream of miR-145, 
suggesting that this miRNA is directly reg-
ulated by OCT4. Electrophoretic mobility 
shift assays as well as chromatin immu-
noprecipitation confirmed occupancy of 
this site by OCT4; reporter assays sug-
gested that OCT4 represses transcription 
of miR-145. Thus, the authors propose a 
model in which reciprocal negative regu-
lation of miR-145 and OCT4 establishes 
an irreversible switch from a low miR-145/
high OCT4 state under self-renewal con-
ditions to a high miR-145/low OCT4 state, 
priming cells to initiate a differentiation 
program.
Given the proposed role for miR-145 in 
silencing the pluripotency program dur-
ing ES cell differentiation, it is perhaps 
surprising that this miRNA also appears 
to repress pluripotency factors in undif-
ferentiated stem cells. This suggests 
complementary, yet distinct, functions 
for this miRNA in stem cells versus differ-
entiating cells. Maintenance of pluripo-
tency in ES cells is highly sensitive to the 
dosage of transcriptional regulators such 
as OCT4 and SOX2, especially as their 
reciprocal activation can rapidly drive 
an irreversible positive feedback loop 
(Chew et al., 2005). It is therefore likely 
that miR-145 buffers ES cells from such 
runaway activation cascades (Figure 1), 
a function in line with current models in 
which miRNAs tune, rather than silence, 
expression of target genes. At the same 
time, reciprocal miR-145/OCT4 inhibition 
allows ES cells to activate a self-reinforc-
ing switch that silences the self-renewal 
program in response to differentiation 
signals. Given this role for miR-145 in 
the switch from pluripotency to cell fate 
commitment, it is possible that inhibition 
of miR-145 might be a useful strategy 
to enhance the efficiency of generating 
induced pluripotent stem cells.
A number of important questions 
remain. Although Xu and colleagues 
demonstrate convincingly that OCT4 is 
bound to a region ?1 kb upstream of 
miR-145 and that this sequence has reg-
ulatory activity in reporter assays, direct 
OCT4-mediated regulation of endoge-
nous miR-145 has yet to be established. 
Moreover, it is likely that the identified 
OCT4-bound cis-regulatory sequence is 
an enhancer element rather than a proxi-
mal promoter. Promoters for miRNAs 
are rarely located immediately upstream 
of the pre-miRNA encoding sequences 
and are often many kilobases removed 
in genomic space. Additionally, miR-145 
is located in a cluster with miR-143, and 
therefore the two miRNAs are likely to 
be cotranscribed. Indeed, cloning data 
from a panel of murine and human tis-
sues demonstrates that miR-143 is coex-
pressed in virtually all samples where 
miR-145 is detected, including ES cells 
(Landgraf et al., 2007). Notably, the regu-
latory element described in this study is 
located between miR-143 and miR-145, 
suggesting that both miRNAs might be 
subject to repression by OCT4. In light 
of the genomic organization of these 
miRNAs, additional studies to investi-
gate whether miR-143 regulates human 
ES cell pluripotency and differentiation 
are warranted.
The identification of miR-145 as a 
potential regulator of ES cell pluripo-
tency and self-renewal is particularly 
intriguing given the evidence pointing to 
a tumor suppressor role for this miRNA in 
numerous human malignancies. Human 
tumors and cancer cell lines from col-
orectal, breast, prostate, and cervical 
carcinomas frequently exhibit reduced 
expression of miR-145 and miR-143. 
Functional studies including in vitro 
analyses of cell proliferation and sur-
vival as well as xenograft experiments 
demonstrate the potent antitumorigenic 
activity of these miRNAs (Sachdeva et 
al., 2009). miR-145 directly targets mul-
tiple canonical oncogenic pathways, 
including those controlled by Ras and 
Myc (Chen et al., 2009; Sachdeva et al., 
2009), providing a mechanistic basis for 
these findings. Given the newly appreci-
ated role of miR-145 in ES cell biology, 
loss of function of this miRNA may also 
potentiate tumorigenesis by promoting a 
program of aberrant self-renewal in pre-
neoplastic cells. Indeed, the initial data 
suggesting that miR-145 has tumor sup-
pressor activity came from the analysis 
of colorectal adenocarcinoma (Michael 
et al., 2003), a tumor type likely to 
figure 1. A MicroRnA-Regulated stem cell Balancing Act
MicroRNAs of the miR-302 and miR-371 families have been implicated in the maintenance of the self-
renewal programs of human ES cells by targeting multiple cell cycle regulatory proteins. Core regulators 
of human ES cell pluripotency—OCT4, SOX2, and KLF4—are targeted directly by miR-145, ensuring 
that the tight control of ES cell proliferation and differentiation is maintained (Xu et al., 2009). Reciprocal 
inhibition of miR-145 and OCT4 may contribute to irreversible silencing of self-renewal and pluripotency 
programs upon initiation of ES cell differentiation. Conversely, many tumors underexpress miR-145, sug-
gesting that this miRNA might function more generally to maintain differentiated, nonproliferative states.Cell 137, May 15, 2009 ©2009 Elsevier Inc. 607
arise from colonic crypt stem cells that 
have lost the normal restraints on self-
renewal. Further investigation is needed 
to directly assess to what extent the 
activities and targets of miR-145 in ES 
cells are relevant to its tumor-suppres-
sive effects.
In light of the Xu et al. study, it is 
instructive to consider the ground-
breaking genetic analyses of lin-4 in the 
worm Caenorhabditis elegans almost 30 
years ago. In these studies, the authors 
reasoned that this gene product (later 
determined to be an miRNA) acted as 
a suppressor of self-renewal of multiple 
worm cell lineages (Chalfie et al., 1981). 
Subsequent work identified lin-28, a fac-
tor now known to be associated with 
pluripotency in mammals, as a target 
of lin-4 and its mammalian orthologs 608 Cell 137, May 15, 2009 ©2009 Elsevier I(Nimmo and Slack, 2009). The new work 
of Xu and colleagues reveals a parallel 
pathway through which miR-145 acts 
to silence multiple pluripotency factors 
during the switch from self-renewal to 
lineage commitment. These similari-
ties predict that inactivation of miR-145 
might broadly influence diverse stem cell 
lineages, a hypothesis that awaits direct 
testing through loss-of-function studies 
in animals.
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